Quick generic drug approval bulletin for today. If you have a family member or other loved who suffers from hypertension, the U.S. Food and Drug Administration has approved Mylan’s new generic version of Teveten (eprosartan) which treat hypertension. Mylan has announced that it is shipping its generic version of Teveten immediately.
According to the Mayo Clinic, hypertension (or high blood pressure) is a common condition in which the force of the blood against your artery walls is high enough that it may eventually cause health problems, such as heart disease. Blood pressure is determined by the amount of blood your heart pumps and the amount of resistance to blood flow in your arteries. The more blood your heart pumps and the narrower your arteries, the higher your blood pressure. Uncontrolled high blood pressure increases the risk of serious health problems, including heart attack and stroke.
Considering a thirty-day supply of brand-name Teveten is currently running more than $100, this could easily be a huge savings for many hypertension patients, so anyone with a family member or loved one on Teveten should ask their doctor if they are an appropriate candidate for the generic eprosartan.
Do you or a loved one use Teveten to treat hypertension? Tell us about it!
- FDA Approves Generic Version of Blood Pressure Drug Plendil (Felodipine)
- Quick Generic Drug News: FDA Approves Generic Version of Anti-Epileptic Drug Keppra XR
- Generic Drug News: FDA Approves First Generic Version of Zyprexa For Schizophrenia and Bipolar
- Generic Drug News: FDA Approves Mylan’s Version of Keppra XR for Epileptic Seizures
- Generic Drug Alert: FDA Approves Release of Generic Version of Protonix (Pantoprazole)